Top

Published in:

01-09-2013 | Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Prostate Related Urinary Tract Infections

Authors: David Osborn, Melissa Kaufman, W. Stuart Reynolds, Roger Dmochowski

Published in: Current Bladder Dysfunction Reports | Issue 3/2013

Abstract

Usually both acute and chronic bacterial prostatitis can be successfully treated with a 28-day course of fluoroquinolones. However, a significant portion of men will develop a recurrent infection. Host factors such as diabetes and urinary tract manipulation predispose patients to develop chronic bacterial prostatitis or an abscess. Pathogen factors such as the ability to form a biofilm and antibiotic resistance also lead to failures. Difficulty achieving adequate antibiotic concentration in prostatic tissue and more virulent bacteria are just two of the factors that make the treatment of chronic bacterial prostatitis more complex and less successful than the treatment of acute bacterial prostatitis. Increasing resistance to fluoroquinolones among bacteria in the Enterobacteraceae family may make treating chronic bacterial prostatitis even more challenging in the future.

Krieger JN, Ross SO, Simonsen JM. Urinary tract infections in healthy university men. J Urol. 1993;149:1046–8.PubMed

la Rosette de JJ, Hubregtse MR, Meuleman EJ, et al. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41:301–7.CrossRef

Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med. 1989;110:138–50.PubMedCrossRef

Cohen J, Powderly WG, Opal SM. Infectious Diseases. Philadelphia, PA: Mosby Incorporated; 2010.

•• Yoon BI, Kim S, Han D-S, et al. Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother. 2012;18:444–50. Excellent retrospective study that, looks for factors that predispose patients to developing chronic bacterial prostatitis.PubMedCrossRef

Ha U-S, Kim ME, Kim CS, et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents. 2008;31 Suppl 1:S96–S101.PubMedCrossRef

Millan-Rodriguez F, Palou J, Bujons-Tur A, et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol. 2006;24:45–50.PubMedCrossRef

Blacklock NJ. The anatomy of the prostate: relationship with prostatic infection. Infection. 1991;19 Suppl 3:S111–4.PubMedCrossRef

Hua L-X, Zhang J-X, Wu H-F, et al. The diagnosis and treatment of acute prostatitis: report of 35 cases. Zhonghua Nan Ke Xue. 2005;11:897–9.PubMed

10.

• Nagy V, Kubej D. Acute bacterial prostatitis in humans: current microbiological spectrum, sensitivity to antibiotics and clinical findings. Urol Int. 2012;89:445–50. Retrospective review of 192 patients with acute bacterial prostatitis.PubMedCrossRef

11.

• Minamida S, Satoh T, Tabata K, et al. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Urology. 2011;78:1235–9. Excellent study that examined the important issue of increasing resistance of Escherichia coli.PubMedCrossRef

12.

Neal DEJ, Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate. 1992;20:105–11.PubMedCrossRef

13.

Kravchick S, Cytron S, Agulansky L, Ben-Dor D. Acute prostatitis in middle-aged men: a prospective study. BJU Int. 2004;93:93–6.PubMedCrossRef

14.

Becopoulos T, Georgoulias D, Constantinides C, et al. Acute prostatitis: which antibiotic to use first. J Chemother. 1990;2:244–6.PubMed

15.

Benway BM, Moon TD. Bacterial prostatitis. Urol Clin North Am. 2008;35:23–32. v.PubMedCrossRef

16.

Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000;164:76–80.PubMedCrossRef

17.

Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236–7.PubMedCrossRef

18.

Stamey TA, Meares EM, Winningham DG. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol. 1970;103:187–94.PubMed

19.

Nickel JC: (2011). Campbell-Walsh Urology 10th Edition Review. Edited by McDougal WS, Wein AJ, Kavoussi LR, et al. Philadelphia, PA: Saunders; 2011: 327-356.

20.

Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006;7:320–8.PubMedCrossRef

21.

Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492–518.PubMed

22.

McNaughton Collins M, Fowler FJJ, Elliott DB, et al. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? Urology. 2000;55:403–7.PubMedCrossRef

23.

Andrews SJ, Brooks PT, Hanbury DC, et al. Ultrasonography and abdominal radiography versus intravenous urography in investigation of urinary tract infection in men: prospective incident cohort study. BMJ. 2002;324:454–6.PubMedCrossRef

24.

Schaeffer AJ. Review of norfloxacin in complicated and recurrent urinary tract infections. Eur Urol. 1990;17 Suppl 1:19–23.PubMed

25.

Weidner W, Schiefer HG, Brähler E. Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol. 1991;146:350–2.PubMed

26.

Naber KG, Busch W, Focht J. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents. 2000;14:143–9.PubMedCrossRef

27.

Wagenlehner FM, Naber KG. Antimicrobial treatment of prostatitis. Expert Rev Anti Infect Ther. 2003;1:275–82.PubMedCrossRef

28.

Krieger JN, Ross SO, Limaye AP, Riley DE. Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis. Urology. 2005;66:721–5.PubMedCrossRef

29.

Krieger JN, McGonagle LA. Diagnostic considerations and interpretation of microbiological findings for evaluation of chronic prostatitis. J Clin Microbiol. 1989;27:2240–4.PubMed

30.

• Perletti G, Skerk V, Magri V, et al. Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). Mol Med Rep. 2011;4:1035–44. Authors propose that macrolides should be used more to treat bacterial prostatitis because of their excellent pharmacokinetic and pharmacodynamic properties.PubMed

31.

El-Hakim A. Chronic prostatitis/chronic pelvic pain syndrome: is there a role for local drug infiltration therapy? J Endourol. 2004;18:227–31.PubMedCrossRef

32.

• Kolumbic Lakos A, Skerk V, Malekovic G, et al. A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. J Chemother. 2011;23:350–3. Prospective study that successfully gave chronic bacterial prostatitis patients parenteral antibiotics prior to oral antibiotics.PubMed

33.

Barnes RW, Hadley HL, O'Donoghue EP. Transurethral resection of the prostate for chronic bacterial prostatitis. Prostate. 1982;3:215–9.PubMedCrossRef

34.

Nickel JC, Costerton JW, McLean RJ, Olson M. Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. J Antimicrob Chemother. 1994;33(Suppl A):31–41.PubMedCrossRef

35.

Barozzi L, Pavlica P, Menchi I, et al. Prostatic abscess: diagnosis and treatment. AJR Am J Roentgenol. 1998;170:753–7.PubMedCrossRef

36.

Ludwig M, Schroeder-Printzen I, Schiefer HG, Weidner W. Diagnosis and therapeutic management of 18 patients with prostatic abscess. Urology. 1999;53:340–5.PubMedCrossRef

37.

Kinahan TJ, Goldenberg SL, Ajzen SA, Cooperberg PL, English RA. Transurethral resection of prostatic abscess under sonographic guidance. Urology. 1991;37:475–7.PubMedCrossRef

38.

Bachor R, Gottfried HW, Hautmann R. Minimal invasive therapy of prostatic abscess by transrectal ultrasound-guided perineal drainage. Eur Urol. 1995;28:320–4.PubMed

39.

Trauzzi SJ, Kay CJ, Kaufman DG, Lowe FC. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology. 1994;43:629–33.PubMedCrossRef

40.

Orakwe JC, Okafor PIS. Genitourinary tuberculosis in Nigeria; a review of thirty-one cases. Niger J Clin Pract. 2005;8:69–73.PubMed

41.

Thornhill BA, Morehouse HT, Coleman P, Hoffman-Tretin JC. Prostatic abscess: CT and sonographic findings. AJR Am J Roentgenol. 1987;148:899–900.PubMedCrossRef

42.

Washecka R, Rumancik WM. Prostatic abscess evaluated by serial computed tomography. Urol Radiol. 1985;7:54–6.PubMedCrossRef

43.

Granados EA, Riley G, Salvador J, Vincente J. Prostatic abscess: diagnosis and treatment. J Urol. 1992;148:80–2.PubMed

44.

Varkarakis J, Sebe P, Pinggera G-M, et al. Three-dimensional ultrasound guidance for percutaneous drainage of prostatic abscesses. Urology. 2004;63:1017–20. discussion 1020.PubMedCrossRef

Title: Prostate Related Urinary Tract Infections
Authors: David Osborn
Melissa Kaufman
W. Stuart Reynolds
Roger Dmochowski
Publication date: 01-09-2013
Publisher: Springer US
Published in: Current Bladder Dysfunction Reports / Issue 3/2013
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-013-0194-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prostate Related Urinary Tract Infections

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2013

Genitourinary Tuberculosis; An Update

Management of Recurrent Neurogenic Bladder Cystitis

The Management of Acute Urinary Retention: Treating the Curse of the Aging Male

Complications of Fungal Cystitis

Urinary Retention and Incontinence after Low-Dose-Rate Brachytherapy for Prostate Cancer

Benign Prostate Hyperplasia and Bladder Stones: An Update